Haemophilus Influenzae Type b (Hib) Infection Completed Phase 3 Trials for Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (DB10990)

IndicationStatusPhase
DBCOND0045329 (Haemophilus Influenzae Type b (Hib) Infection)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01025544Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in ChinaPrevention